TRANSCENDENTAL SLEEP Trademark

Trademark Overview


On Thursday, February 8, 2024, a trademark application was filed for TRANSCENDENTAL SLEEP with the United States Patent and Trademark Office. The USPTO has given the TRANSCENDENTAL SLEEP trademark a serial number of 98397443. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, July 30, 2024. This trademark is owned by Kumato. The TRANSCENDENTAL SLEEP trademark is filed in the Pharmaceutical Products category with the following description:

Herbal supplements
transcendental sleep

General Information


Serial Number98397443
Word MarkTRANSCENDENTAL SLEEP
Filing DateThursday, February 8, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, July 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesHerbal supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 8, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKumato
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSignal Hill, CA 90755

Trademark Events


Event DateEvent Description
Thursday, February 8, 2024NEW APPLICATION ENTERED
Friday, June 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 30, 2024NON-FINAL ACTION E-MAILED
Tuesday, July 30, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 30, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 30, 2024ASSIGNED TO EXAMINER